Cargando…
Novel Heparan Sulfate-Binding Peptides for Blocking Herpesvirus Entry
Human cytomegalovirus (HCMV) infection can lead to congenital hearing loss and mental retardation. Upon immune suppression, reactivation of latent HCMV or primary infection increases morbidity in cancer, transplantation, and late stage AIDS patients. Current treatments include nucleoside analogues,...
Autores principales: | Dogra, Pranay, Martin, Emily B., Williams, Angela, Richardson, Raphael L., Foster, James S., Hackenback, Nicole, Kennel, Stephen J., Sparer, Tim E., Wall, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436313/ https://www.ncbi.nlm.nih.gov/pubmed/25992785 http://dx.doi.org/10.1371/journal.pone.0126239 |
Ejemplares similares
-
Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings
por: Jackson, Joseph W., et al.
Publicado: (2019) -
Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry
por: Suryawanshi, Rahul K., et al.
Publicado: (2021) -
A Heparan-Dependent Herpesvirus Targets the Olfactory Neuroepithelium for Host Entry
por: Milho, Ricardo, et al.
Publicado: (2012) -
Archaic connectivity between the sulfated heparan sulfate and the herpesviruses – An evolutionary potential for cross-species interactions
por: Elste, James, et al.
Publicado: (2023) -
In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection
por: Gillet, Laurent, et al.
Publicado: (2009)